NCT07742345Recruiting
Clinical Study of Coronary Extension Catheter
A Prospective, Multicenter, Single-Arm Clinical Study Evaluating the Safety and Efficacy of Coronary Extension Catheter in Percutaneous Coronary Intervention
Source: ClinicalTrials.gov · Last updated 3 Aug 2026
Brief summary (registry, in English)
This prospective, multicenter, single-arm study plans to enroll 69 subjects. Subjects meeting the protocol criteria will receive treatment with coronary extension catheters. The safety and efficacy of these catheters in percutaneous coronary intervention will be assessed through the collection and analysis of efficacy and safety endpoints during treatment and follow-up.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 69 (estimated)
- First submitted
- 23 Jul 2026
- Start date
- 25 Jun 2026
- Primary completion date
- 30 Apr 2027
- Lead sponsor
- BrosMed Medical Co., Ltd
- Diseases
- Coronary artery disease
- NCT number
- NCT07742345
What you commit to
- Study type: Interventional
- Planned participants: 69
- From 25 Jun 2026 to the primary completion date, 30 Apr 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Acute myocardial infarction occurring within 7 days prior to enrollment;
- Concurrent severe hepatic or renal disease, or other severe systemic conditions that render the patient unsuitable for PCI;
- Currently participating in another clinical trial of a drug or medical device without having reached the primary endpoint or completed the trial;
Other illness
- Unprotected left main coronary artery disease;
- Known intolerance to anticoagulant or antiplatelet therapy, or known allergy to contrast media;
- Any other condition that, in the investigator's opinion, makes the patient ineligible for participation in this study.
Other
- Reference vessel diameter \< 2 mm;
- Presence of thrombus in the target vessel;
- Pregnant or lactating women;
Who the study is looking for
- Age ≥18 years, regardless of gender;
- Patients suitable for percutaneous coronary intervention (PCI) and for whom the use of an extension catheter is planned to assist the intervention;
- Ability to understand the purpose of the study, willingness to voluntarily participate, and ability to provide written informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Beijing Friendship Hospital, Capital Medical University Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.